Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis.

Ollech JE, Normatov I, Peleg N, Dalal SR, Pekow J, Micic D, Cohen RD, Rubin DT, Sakuraba A. Efficacy of biosimilar infliximab CT-P13 among inpatients with severe steroid-refractory colitis. Int J Colorectal Dis. 2020 Nov; 35(11):2113-2116.

View in: PubMed